The protective effect was more notable for nonfatal stroke, with a 39% relative risk reduction
Ultimately, patient safety is best served through regulated, evidence-based care
Patent filings have concentrated on sequence optimization, receptor balance, and dosing regimens [5, 6], while scientific reviews increasingly position these compounds as the next frontier beyond single-target GLP-1 therapy [1, 2]
Suppression of the malignant phenotype in pancreatic cancer by the overexpression of phospholipid hydroperoxide glutathione peroxidase (PhGPx)
For someone on the edge of prediabetes, that shift can meaningfully alter their long-term metabolic trajectory
Abdelmouttalib A, Meziane M, Senouci K